Close Menu

NEW YORK (360Dx) – MedMira said today that it has received CE marking for its Multiplo TP/HIV multiplex rapid test, allowing the firm to market and distribute the test throughout the European Union, and in global markets that accept products with CE marking.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.